Seeing Is Believing
Currently out of the existing stock ratings of Biren Amin, 24 are a HOLD (15.79%), 127 are a BUY (83.55%), 1 are a SELL (0.66%).
Analyst Biren Amin, currently employed carries an average stock price target met ratio of 55.61% that have a potential upside of 32.6% achieved within 244 days. Previously, Biren Amin worked at JEFFERIES.
Biren Amin’s has documented 310 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CCCC, C4 Therapeutics at 11-Aug-2023.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9
$3.01 (50.25%)
40
8 days ago
0/6 (0%)
$1.7 (23.29%)
Buy
162.9
$156.91 (2619.53%)
162.9
1 years 4 months 11 days ago
1/4 (25%)
$125.81 (339.20%)
618
Buy
235.53
$229.54 (3832.05%)
2 years 10 months 19 days ago
0/1 (0%)
$109.92 (87.51%)
Buy
6.87
$5.74 (507.96%)
3 years 4 months 10 days ago
0/1 (0%)
$3.72 (118.10%)
Buy
7
$4.56 (186.89%)
7 years 3 months 6 days ago
0/2 (0%)
$4.6 (103.40%)
What Year was the first public recommendation made by Biren Amin?